Study Recruitment for Phase III Oncology Drug -- US & Europe

February 9, 2018

Challenge

Create an effective strategy for sites in the US and Europe, considering high sensitivity with Oncology sites and patients to identify and recruit patients with very strict I/E criteria for existing chemotherapy patients having either solid tumor or hematologic malignancies.

Solution

Implemented our ThreeWire Chart Review™ and Enrollment Assistant™ services at selected sites in Europe and the US, along with a study website and support materials for 45 countries.

Results

Reviewed a total of 3,871 charts, with 1,095 passing pre-screening. Contributed a total of 102 enrollments across 14 sites. The highest enrolling site was one which utilized our Enrollment Assistant service.

“We are so grateful for ThreeWire. You have an outstanding team in terms of professionalism and customer service that separates you from the rest and you should be very proud.”

-- Case Study Study Team Lead Top 5 Pharma Company

Previous Flipbook
Patient Enrollment for Phase IB Tobacco Research Study
Patient Enrollment for Phase IB Tobacco Research Study

Challenge: A top-tier CRO, had been running their study for six months when enrollment, as well as new scre...

Next Flipbook
Study Rescue for a Phase II Dermatology Study US & Europe
Study Rescue for a Phase II Dermatology Study US & Europe

Challenge: Rescue enrollment for 100-participant study across 32 sites globally, that had enrolled only 20 ...